kabutan

TSUMURA & CO.(4540) Summary

4540
TSE Prime
TSUMURA & CO.
3,836
JPY
-20
(-0.52%)
Mar 13, 3:30 pm JST
24.06
USD
Mar 13, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
11.7
PBR
0.94
Yield
3.75%
Margin Trading Ratio
6.74
Stock Price
Mar 13, 2026
Opening Mar 13, 9:00 am
3,826 JPY 24.02 USD
Previous Close Mar 12
3,856 JPY 24.25 USD
High Mar 13, 9:41 am
3,863 JPY 24.27 USD
Low Mar 13, 9:00 am
3,824 JPY 24.00 USD
Volume
247,900
Trading Value
0.95B JPY 5.97M USD
VWAP
3836.73 JPY 24.07 USD
Minimum Trading Value
383,600 JPY 2,406 USD
Market Cap
0.29T JPY 1.85B USD
Number of Trades
768
Liquidity & Number of Trades
As of Mar 13, 2026
Liquidity
High
1-Year Average
1,444
1-Year High May 13, 2025
8,192
Margin Trading
Date Short Interest Long Margin Positions Ratio
Mar 6, 2026 29,500 113,400 3.84
Feb 27, 2026 32,500 126,700 3.90
Feb 20, 2026 73,000 127,900 1.75
Feb 13, 2026 31,400 127,800 4.07
Feb 6, 2026 29,600 124,500 4.21
Company Profile
TSUMURA & CO. is the leading company specializing in Kampo medicines, expanding its focus on medications for the elderly, cancer patients, and women's health. The company is also developing its business in China.
Sector
Pharmaceuticals
TSUMURA & CO. primarily engages in the manufacture and sale of Kampo medicines, offering both prescription and over-the-counter pharmaceuticals. The company has established an integrated production system from the cultivation of raw medicinal herbs to product manufacturing, ensuring thorough quality control. In Japan, TSUMURA & CO. has secured its position as the undisputed top manufacturer of prescription Kampo preparations. In recent years, the company has been actively expanding into the Chinese market, strengthening its local production and sales capabilities through capital and business alliances with local enterprises. Furthermore, TSUMURA & CO. is advancing its global business operations, including drug development in the United States and cultivation of raw medicinal herbs in Laos. The company focuses on promoting Kampo medicine and developing evidence-based Kampo preparations to address the diversifying needs in healthcare.